EWSR1 and osteosarcoma: These findings are supported by Shah and colleagues whose work highlights that EWS and osteosarcoma patients with high ctDNA levels have a significantly increased risk of disease-related death and that a rise in ctDNA levels is predictive of patient relapse (43).